References

The radiation response of human malignant melanoma cells grown in vitro

1971 · External reference

Radiation sensitivity in vitro of primary tumors and metastatic lesions of malignant melanoma

1992 · External reference

The radiosensitivity of melanoma cells in culture

10.1259/0007-1285-44-526-816 · 1971 · External reference

Radiation therapy of malignant melanoma: Experience with high individual treatment doses

10.1002/1097-0142(197612)38:6<2258::aid-cncr2820380611>3.0.co;2-h · 1976 · External reference

The radiosensitivity of melanoma cells in culture

1972 · External reference

The radiation response of human malignant melanoma cells in vitro and in vivo

1972 · External reference

A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma

10.1016/0360-3016(85)90042-2 · 1985 · External reference

Fraction size in external beam radiation therapy in the treatment of melanoma

10.1016/0360-3016(91)90053-7 · 1991 · External reference

Dose escalation of whole-brain radiotherapy for brain metastases from melanoma

10.1016/j.ijrobp.2009.05.001 · 2010 · External reference

Radiation therapy of intracranial malignant melanoma

10.1016/0167-8140(95)01691-0 · 1996 · External reference

Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: A 20-year experience

10.1016/s0360-3016(99)00066-8 · 1999 · External reference

Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: An Eastern Cooperative Oncology Group study (E 6397)

10.1200/jco.2005.01.8747 · 2005 · External reference

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival

10.1016/s0360-3016(98)00272-7 · 1998 · External reference

Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma

10.3171/jns/2008/109/12/s19 · 2008 · External reference

Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control

10.1186/1748-717x-6-34 · 2011 · External reference

Oligometastases

10.1200/jco.1995.13.1.8 · 1995 · External reference

Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)

10.1245/s10434-012-2398-z · 2012 · External reference

Recurrence and survival outcomes after percutaneous thermal ablation of oligometastatic melanoma

10.1016/j.mayocp.2015.10.025 · 2016 · External reference

From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors

10.2967/jnumed.108.057307 · 2009 · External reference

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy

10.1016/j.ijrobp.2007.10.059 · 2008 · External reference

Some factors of importance in the radiation treatment of malignant melanoma

10.1016/s0167-8140(86)80048-2 · 1986 · External reference

Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT

10.1016/j.rpor.2015.03.004 · 2015 · External reference

Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine

10.1016/j.ijrobp.2013.12.042 · 2014 · External reference

Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma

10.1007/s00280-015-2873-x · 2015 · External reference

Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma

10.1007/s00280-011-1703-z · 2011 · External reference

Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial

10.1001/jama.2014.13943 · 2014 · External reference